ENTITY

Jiangsu Hengrui Pharmaceuticals (1276 HK)

316
Analysis
Health Care • China
Jiangsu Hengrui Pharmaceuticals is a global biopharmaceutical company engaged in the research, development, manufacturing, and commercialization of innovative and high-quality drugs. The company focuses on therapeutic areas including oncology, metabolic and cardiovascular diseases, immunological and respiratory diseases, and neuroscience. It was founded in 1970 and is headquartered in Lianyungang, Jiangsu, China.
more
Exchange Announcement • 14 Oct 2026 16:42

Next Day Disclosure Return

Exchange Announcement • 14 Oct 2026 16:30

Notice Of Board Meeting

Exchange Announcement • 13 Oct 2026 16:50

Next Day Disclosure Return

Exchange Announcement • 29 Sep 2026 12:28

Inside Information Announcement And Overseas Regulatory Announcement - Entering Into License Agreement For Hrs-1596 With Novo Nordisk A/S

Exchange Announcement • 24 Sep 2026 20:14

Poll Results Of The 2026 First Extraordinary Shareholders' Meeting

x